logo

PACB

Pacific Biosciences·NASDAQ
--
--(--)
--
--(--)

PACB fundamentals

Pacific Biosciences (PACB) expects to report earnings on Feb 12, 2026, with estimated revenue of 43.02M (YoY +9.69%), and EPS at -0.1437 (YoY -1537.00%).
Revenue estimate / YoY
43.02M
+9.69%
EPS estimate / YoY
-0.1437
-1537.00%
Report date
Feb 12, 2026
Earnings Call
5:00 PM on Feb 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

PACB has released its 2025 Q3 earnings report, with revenue of 38.44M, reflecting a YoY change of -3.82%, and net profit of -38.00M, showing a YoY change of 37.42%. The Sankey diagram below clearly presents PACB's revenue sources and cost distribution.

Key Indicators

Pacific Biosciences (PACB) key financial stats and ratios, covering profitability, financial health, and leverage.
Pacific Biosciences (PACB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Pacific Biosciences (PACB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Pacific Biosciences (PACB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Pacific Biosciences (PACB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Pacific Biosciences (PACB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield